Copyright
©2013 Baishideng Publishing Group Co.
World J Hepatol. Apr 27, 2013; 5(4): 160-169
Published online Apr 27, 2013. doi: 10.4254/wjh.v5.i4.160
Published online Apr 27, 2013. doi: 10.4254/wjh.v5.i4.160
Table 1 Univariate analysis of diet and melatonin use and its duration
Liver weight (g) | P value | Liver weight/body weight (%) | P value | Portal vein pressure (mmHg) | P value | |
Diet | ||||||
HFD | 13.3 ± 2.8 | < 0.001 | 3.5 ± 0.5 | < 0.001 | 11.9 ± 2.7 | < 0.001 |
RD | 9.1 ± 1.3 | BV | 2.4 ± 0.3 | BV | 8.0 ± 1.7 | BV |
Melatonin | ||||||
10 mg/kg | 11.2 ± 2.5 | < 0.001 | 3.0 ± 0.5 | < 0.001 | 10.5 ± 2.6 | 0.01 |
5 mg/kg | 11.3 ± 2.3 | < 0.001 | 3.0 ± 0.6 | < 0.001 | 10.3 ± 2.8 | 0.03 |
0 mg/kg | 16.2 ± 2.3 | BV | 4.0 ± 0.5 | BV | 13.0 ± 3.5 | BV |
Duration | ||||||
8 wk | 12.0 ± 3.6 | 0.86 | 3.2 ± 0.7 | 0.71 | 10.1 ± 2.5 | 0.02 |
4 wk | 12.2 ± 2.6 | BV | 3.2 ± 0.7 | BV | 12.0 ± 3.3 | BV |
- Citation: Hatzis G, Ziakas P, Kavantzas N, Triantafyllou A, Sigalas P, Andreadou I, Ioannidis K, Chatzis S, Filis K, Papalampros A, Sigala F. Melatonin attenuates high fat diet-induced fatty liver disease in rats. World J Hepatol 2013; 5(4): 160-169
- URL: https://www.wjgnet.com/1948-5182/full/v5/i4/160.htm
- DOI: https://dx.doi.org/10.4254/wjh.v5.i4.160